市場調查報告書
商品編碼
1435046
美容醫學市場:按產品類型、性別和最終用戶 - 2024-2030 年全球預測Aesthetic Medicine Market by Products (Body Contouring Devices, Cosmetic Implants, Facial Aesthetic Products), Type (Invasive Procedures, Non-Invasive Procedures), Gender, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年美容醫學市場規模為818.1億美元,預計2024年將達到915.9億美元,2030年將達到1846.5億美元,複合年成長率為12.33%。
全球美容醫學市場
主要市場統計 | |
---|---|
基準年[2023] | 818.1億美元 |
預測年份 [2024] | 915.9億美元 |
預測年份 [2030] | 1846.5億美元 |
複合年成長率(%) | 12.33% |
美容醫學是一個快速發展的多學科領域,涵蓋各種醫療程序,透過微創或非侵入性程序增強患者的外表、自尊和整體幸福感。這種專業的醫療實踐將藝術與最新的科學進步相結合,解決與老齡化、皮膚健康、身體輪廓和臉部美容相關的各種問題。整容手術設備和技術的技術進步,以及對非侵入性整容手術日益成長的需求,正在加速對美容醫學的需求。然而,有限的保險報銷範圍和嚴格的監管指南是擴大這些治療方法使用的障礙。該領域的先進研究和開發促進了創新美容醫療產品的開發,這些產品具有更高的安全性和最短的術後停機時間。市場參與者正在整合遠端醫療平台和虛擬諮詢等數位技術,以覆蓋更多人,同時提高患者便利性。
區域洞察
由於知名製造商的不斷增加以及促進創新和產品開拓的競爭環境,美洲是一個成熟的美容醫學市場。在美國和加拿大,人們對各種非手術治療方法(例如注射和塑身產品)的認知不斷增強,推動了該地區對美容醫學的需求。在美容標準和中階可支配收入不斷成長等文化因素的推動下,亞太地區 (APAC) 對美容醫學的需求正在快速成長。特別是韓國、中國和日本的消費者正在優先考慮注重抗老化功效的護膚品,從而改善了美容醫學市場。歐洲在皮膚病學研究方面擁有悠久的傳統,導致美容醫學的創新。國際醫療旅遊正在擴展到波蘭、匈牙利和捷克共和國等國家,讓患者以低廉的價格獲得高品質的照護。歐洲藥品管理局 (EMA) 在監督歐盟境內美容醫療產品的市場授權方面發揮著重要作用。
FPNV定位矩陣
FPNV定位矩陣對於評估美容醫學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對美容醫學市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-美容醫學市場的市場規模和預測是多少?
2-美容醫學市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3-美容醫學市場的技術趨勢和法律規範是什麼?
4-美容醫學市場主要廠商的市場佔有率是多少?
5-進入美容醫學市場的合適型態和策略手段是什麼?
[183 Pages Report] The Aesthetic Medicine Market size was estimated at USD 81.81 billion in 2023 and expected to reach USD 91.59 billion in 2024, at a CAGR 12.33% to reach USD 184.65 billion by 2030.
Global Aesthetic Medicine Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 81.81 billion |
Estimated Year [2024] | USD 91.59 billion |
Forecast Year [2030] | USD 184.65 billion |
CAGR (%) | 12.33% |
Aesthetic medicine, also known as cosmetic medicine, is a rapidly growing interdisciplinary field encompassing various medical practices to enhance the patient's appearance, self-esteem, and overall well-being through minimally invasive or non-invasive procedures. This specialized medical practice combines artistry with the latest scientific advancements to address an array of concerns related to aging, skin health, body contouring, and facial aesthetics. Technological advancements in cosmetic surgery equipment and techniques and increasing demand for non-invasive cosmetic procedures have accelerated the need for aesthetic medicines. However, limited reimbursement coverage and strict regulatory guidelines can act as barriers to increasing the use of these medicines. Advanced research in the field has led to the development of innovative aesthetic medicine products with improved safety profiles and minimal downtime post-procedure. Market players are working on integrating digital technologies such as telemedicine platforms or virtual consultations to help reach a wider audience while improving patient convenience.
Regional Insights
The Americas portrays a well-established aesthetic medicine market driven by the increased presence of well-known manufacturers, creating a competitive environment that fuels innovation and product development. Increased awareness about various non-surgical treatments, such as injectables and body contouring products in the U.S. and Canada, has accelerated the demand for aesthetic medicine in the region. In Asia-Pacific (APAC), the demand for aesthetic medicine is rapidly growing due to cultural factors such as beauty standards and increasing disposable incomes among middle-class populations. In particular, South Korean, Chinese, and Japanese consumers prioritize skincare products focusing on anti-aging benefits, creating an improved market for aesthetic medicine. Europe boasts a strong tradition of excellence in dermatology research, leading to innovations within aesthetic medicine over time. International medical tourism to countries such as Poland, Hungary, and the Czech Republic has expanded, where patients can access high-quality treatments at a lower cost. The European Medicines Agency (EMA) plays a crucial role in overseeing market authorization for aesthetic medicine products within the European Union.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Aesthetic Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aesthetic Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Aesthetic Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alma Lasers Ltd. by Shanghai Fosun Pharmaceutica Group Co., Ltd., Bioxis Pharmaceuticals, Black & Black Surgical, Inc., BTL Industries, Candela Corporation, Cutera, Inc., Cynosure Inc., Cytrellis, Inc., Dimeda Instrumente GmBH, Fotona d.o.o., Galderma SA, Inmode Ltd., Johnson & Johnson Services Inc., KARL STORZ SE & Co. KG, Lumenis Be Ltd. by Boston Scientific Corp., Lutronic Inc., Lynton Lasers Ltd., Medytox Inc., Merz Pharma GmbH & Co. KGaA, Millennium Surgical Corp., miraDry, Inc., Quanta System S.p.A. by El.En. S.p.A., Sciton, Inc., Sientra, Inc., Sinclair Pharma Ltd., Solta Medical, Strata Skin Sciences, Venus Concept, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Aesthetic Medicine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aesthetic Medicine Market?
3. What are the technology trends and regulatory frameworks in the Aesthetic Medicine Market?
4. What is the market share of the leading vendors in the Aesthetic Medicine Market?
5. Which modes and strategic moves are suitable for entering the Aesthetic Medicine Market?